PLYMOUTH MEETING, PA — A study published in the February 2026 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that incorporating prostate-specific membrane antigen PET/CT ...

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

A PSMA PET scan found more recurrent prostate cancer at low PSA levels than a standard scan, helping guide more potentially curative treatment decisions. A newer type of prostate cancer scan called 64 ...

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...

At ECR 2026, under the theme "Rays of Knowledge", United Imaging Intelligence (UII) showcased a comprehensive suite of pioneering AI ...

The tissue lining of the vulva and vagina are estrogen-sensitive, and the low levels of estrogen that occur after menopause often cause them to atrophy.

Add Yahoo as a preferred source to see more of our stories on Google. The remains of one of the four children found by archeologists, buried in the Inca sanctuary of Pachacamac, in the coastal desert ...

PYLARIFY TruVu™ (piflufolastat F 18) injection (also known as 18F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and ...

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...